The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Impact of Age, Sex, and Comorbidity on Cancer Therapy and Disease Progression
Abstract
A theme of personalized medicine was highlighted at the 2009 Annual Meeting of the American Society of Clinical Oncology. To this end, the current review focuses on the impact of host characteristics (such as age, sex, and comorbidity) as they pertain to cancer biology, treatment efficacy, and tolerance. Increasing age is associated with complex changes in physiology, including alterations in renal and hepatic function, and decreased bone marrow reserve. These may in turn result in alterations in pharmacokinetics and toxicity related to many commonly used anticancer agents. Using tools, such as the geriatric assessment, may help to elucidate the physiologic age of the patient as opposed to the chronologic age. Increasing age is paralleled by an increase in comorbidity, and comorbidity may have independent prognostic implications and substantially impact medical decision making in the patient with cancer. Numerous biologic ties between cancer and comorbidity exist, one example being an association of diabetes with an increased risk of disease recurrence and mortality in the setting of colon cancer. Biologic features can also vary by sex; several biomarkers with either prognostic or predictive value (ie, excisionrepair cross-complementation group 1 expression, epidermal growth factor receptor mutation, or dihydropyrimidine dehydrogenase polymorphism) may differentiate efficacy or toxicity in males and females. Taken together, age, sex, and comorbidity each encompass a complex array of physiologic and molecular variations that may each aid in personalizing care for the patient with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., & Johnson, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061884 · Cited by 5,761
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
Shepherd, F. A., Rodrigues Pereira, J., Ciuleanu, T., Tan, E. H., Hirsh, V., Thongprasert, S., Campos, D., Maoleekoonpiroj, S., Smylie, M., Martins, R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050753 · Cited by 5,419 · cited 1×
“A phase III trial of the epidermal growth factor receptor (EGFR) inhibitor erlotinib demonstrated improved survival with the agent (compared with placebo) after first- or second-line therapy.(94) The study further identified enhanced response rates among females and those with EGFR mutation, a finding supported by sev…”
ResultPao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., Shenkier, T., Cella, D., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,081
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
Hutchins, L. F., Unger, J. M., Crowley, J. J., Coltman, C. A., & Albain, K. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412706 · Cited by 2,174
DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy
Olaussen, K. A., Dunant, A., Fouret, P., Brambilla, E., André, F., Haddad, V., Taranchon, E., Filipits, M., Pirker, R., Popper, H. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060570 · Cited by 1,727
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
Smith, B. D., Smith, G. L., Hurria, A., Hortobagyi, G. N., & Buchholz, T. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.8983 · Cited by 1,721
Self-citationSmith, T. J., Khatcheressian, J., Lyman, G. H., Ozer, H., Armitage, J. O., Balducci, L., Bennett, C. L., Cantor, S. B., Crawford, J., Cross, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4451 · Cited by 1,636
Cappuzzo, F., Hirsch, F. R., Rossi, E., Bartolini, S., Ceresoli, G. L., Bemis, L., Haney, J., Witta, S., Danenberg, K., Domenichini, I., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji112 · Cited by 1,551
Age and acute myeloid leukemia
Appelbaum, F. R., Gundacker, H., Head, D. R., Slovak, M. L., Willman, C. L., Godwin, J. E., Anderson, J. E., & Petersdorf, S. H. (2006) · Blood · doi:10.1182/blood-2005-09-3724 · Cited by 1,350
Phenotype of frailty: characterization in the women's health and aging studies
Bandeen-Roche, K., Xue, Q.-L., Ferrucci, L., Walston, J., Guralnik, J. M., Chaves, P., Zeger, S. L., & Fried, L. P. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.3.262 · Cited by 1,215 · cited 1×
“This prognostic phenotype has been validated in several large data sets.(57,58) Further research is needed to explore the application of these criteria to older adults with cancer.”
Prognostic Importance of Comorbidity in a Hospital-Based Cancer Registry
Piccirillo, J. F. (2004) · JAMA · doi:10.1001/jama.291.20.2441 · Cited by 1,205
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009 · cited 1×
“The tumor suppressor p16 has been noted to be a potential marker of physiologic age because with aging, p16 expression increases in the tissues of both humans and rodents.(120) Aberrant methylation of the tumor suppressor gene p16 is seen primarily in females and patients of advanced age, a finding seen in both colore…”
BackgroundFasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Effect of Age and Comorbidity in Postmenopausal Breast Cancer Patients Aged 55 Years and Older
Yancik, R. (2001) · JAMA · doi:10.1001/jama.285.7.885 · Cited by 896
Jiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880 · cited 1×
“plete response with neoadjuvant chemotherapy among diabetic patients taking metformin as compared with nondiabetic patients.(76)”
ResultHigh-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
Löwenberg, B., Ossenkoppele, G. J., van Putten, W., Schouten, H. C., Graux, C., Ferrant, A., Sonneveld, P., Maertens, J., Jongen-Lavrencic, M., von Lilienfeld-Toal, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901409 · Cited by 828
Development and Validation of a Prognostic Index for 4-Year Mortality in Older Adults
Lee, S. J. (2006) · JAMA · doi:10.1001/jama.295.7.801 · Cited by 809
Andreyev, H. J. N., Norman, A. R., Oates, J., & Cunningham, D. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10090-9 · Cited by 797
Social networks, social support, and survival after breast cancer diagnosis
Kroenke, C. H., Kubzansky, L. D., Schernhammer, E. S., Holmes, M. D., & Kawachi, I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2846 · Cited by 792
Importance of Functional Measures in Predicting Mortality Among Older Hospitalized Patients
Inouye, S. K. (1998) · JAMA · doi:10.1001/jama.279.15.1187 · Cited by 777
Han, S.-W., Kim, T.-Y., Hwang, P. G., Jeong, S., Kim, J., Choi, I. S., Oh, D.-Y., Kim, J. H., Kim, D.-W., Chung, D. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.388 · Cited by 768
The Effect of Comorbidity on 3-Year Survival of Women with Primary Breast Cancer
Satariano, W. A., & Ragland, D. R. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-2-199401150-00002 · Cited by 731
Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin
Go, R. S., & Adjei, A. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.409 · Cited by 697
Clinical toxicities encountered with paclitaxel (Taxol).
Rowinsky, E. K., Eisenhauer, E. A., Chaudhry, V., Sg, A., & Rc, D. (1993) · PubMed · Cited by 692
Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer
Diab, S. G. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.550 · Cited by 674
Walter, L. C. (2001) · JAMA · doi:10.1001/jama.285.23.2987 · Cited by 674
Lord, R. V., Brabender, J., Gandara, D. R., Alberola, V., Camps, C., Dómine, M., Cardenal, F., Sánchez, J. M., Gumerlock, P. H., Tarón, M., et al. (2002) · PubMed · Cited by 668
Kantarjian, H., O'Brien, S., Cortes, J., Giles, F., Faderl, S., Jabbour, E., Garcia‐Manero, G., Wierda, W., Pierce, S., Shan, J., et al. (2006) · Cancer · doi:10.1002/cncr.21723 · Cited by 610
Schneider, B. P., Wang, M., Radovich, M., Sledge, G. W., Badve, S., Thor, A., Flockhart, D. A., Hancock, B., Davidson, N., Gralow, J., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.1612 · Cited by 604
Trastuzumab-Associated Cardiac Adverse Effects in the Herceptin Adjuvant Trial
Suter, T. M., Procter, M., van Veldhuisen, D. J., Muscholl, M., Bergh, J., Carlomagno, C., Perren, T., Passalacqua, R., Bighin, C., Klijn, J. G. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1611 · Cited by 566
Cancer burden in the aged: an epidemiologic and demographic overview.
Yancik, R. (1997) · PubMed · Cited by 558
Perez, E. A., Suman, V. J., Davidson, N. E., Sledge, G. W., Kaufman, P. A., Hudis, C. A., Martino, S., Gralow, J. R., Dakhil, S. R., Ingle, J. N., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5467 · Cited by 538
Xue, Q.-L., Bandeen-Roche, K., Varadhan, R., Zhou, J., & Fried, L. P. (2008) · The Journals of Gerontology: Series A · doi:10.1093/gerona/63.9.984 · Cited by 484
Maione, P., Perrone, F., Gallo, C., Manzione, L., Piantedosi, F., Barbera, S., Cigolari, S., Rosetti, F., Piazza, E., Robbiati, S. F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.527 · Cited by 478
Cancer burden in the aged: An epidemiologic and demographic overview
Yancik, R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971001)80:7<1273::aid-cncr13>3.0.co;2-4 · Cited by 473
Clinical pharmacokinetics of oxaliplatin: a critical review.
Graham, M. A., Lockwood, G. F., Greenslade, D., Brienza, S., Bayssas, M., & Gamelin, E. (2000) · PubMed · Cited by 455
Frasci, G., Lorusso, V., Panza, N., Comella, P., Nicolella, G., Bianco, A., De Cataldis, G., Iannelli, A., Bilancia, D., Belli, M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.13.2529 · Cited by 447
Sotaniemi, E. A., Arranto, A. J., Pelkonen, O., & Pasanen, M. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90166-1 · Cited by 415
Yancik, R., Wesley, M. N., Ries, L., Havlik, R. J., Long, S., Edwards, B. K., & Yates, J. W. (1998) · PubMed · Cited by 408
Cellular senescence, cancer and aging: the telomere connection
Campisi, J., Kim, S.-H., Lim, C.-S., & Rubio, M. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00160-7 · Cited by 400
Tam, I. Y. S., Chung, L. P., Suen, W. S., Wang, E., Wong, M. C. M., Ho, K. K., Lam, W. K., Chiu, S. W., Girard, L., Minna, J. D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1981 · Cited by 400
Schwab, M., Zanger, U. M., Marx, C., Schaeffeler, E., Klein, K., Dippon, J., Kerb, R., Blievernicht, J., Fischer, J., Hofmann, U., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4182 · Cited by 393
Impact of Diabetes Mellitus on Outcomes in Patients With Colon Cancer
Meyerhardt, J. A., Catalano, P. J., Haller, D. G., Mayer, R. J., Macdonald, J. S., Benson, A. B., & Fuchs, C. S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.125 · Cited by 374
Yancik, R., Wesley, M. N., Ries, L. A. G., Havlik, R. J., Long, S., Edwards, B. K., & Yates, J. W. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980601)82:11<2123::aid-cncr6>3.0.co;2-w · Cited by 361
Asmis, T. R., Ding, K., Seymour, L., Shepherd, F. A., Leighl, N. B., Winton, T. L., Whitehead, M., Spaans, J. N., Graham, B. C., & Goss, G. D. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.8322 · Cited by 332
Ceppi, P., Volante, M., Novello, S., Rapa, I., Danenberg, K. D., Danenberg, P. V., Cambieri, A., Selvaggi, G., Saviozzi, S., Calogero, R., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl300 · Cited by 323
Insulin promotion of colon tumors in rats.
Tran, T. T., Medline, A., & Bruce, W. R. (1996) · PubMed · Cited by 275
Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity
Milano, G., Etienne, M. C., Pierrefite, V, Barberi-Heyob, M., Deporte-Fety, R., & Renée, N. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690098 · Cited by 275
Schuetz, E. G., Furuya, K. N., & Schuetz, J. D. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12089-2 · Cited by 265
Women Experience Greater Toxicity With Fluorouracil-Based Chemotherapy for Colorectal Cancer
Sloan, J. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1491 · Cited by 262
Influence of sex and age on fluorouracil clearance.
Milano, G., Etienne, M. C., Cassuto-Viguier, E., Thyss, A., Santini, J., Frenay, M., Renee, N., Schneider, M., & Demard, F. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1171 · Cited by 260
Unmasking the dynamic interplay between efflux transporters and metabolic enzymes
Benet, L. Z., Cummins, C. L., & Wu, C. Y. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2002.12.002 · Cited by 256
Giacchetti, S., Bjarnason, G., Garufi, C., Genet, D., Iacobelli, S., Tampellini, M., Smaaland, R., Focan, C., Coudert, B., Humblet, Y., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1440 · Cited by 236
Wolpin, B. M., Meyerhardt, J. A., Chan, A. T., Ng, K., Chan, J. A., Wu, K., Pollak, M. N., Giovannucci, E. L., & Fuchs, C. S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9945 · Cited by 231
Physiologic Aspects of Aging: Impact on Cancer Management and Decision Making, Part I
Sawhney, R., Sehl, M., & Naeim, A. (2005) · The Cancer Journal · doi:10.1097/00130404-200511000-00004 · Cited by 214
Bajetta, E., Procopio, G., Celio, L., Gattinoni, L., Della Torre, S., Mariani, L., Catena, L., Ricotta, R., Longarini, R., Zilembo, N., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.167 · Cited by 207
Metformin in Breast Cancer: Time for Action
Goodwin, P. J., Ligibel, J. A., & Stambolic, V. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1630 · Cited by 200
Report of the National Institute on Aging Task Force on Comorbidity
Yancik, R., Ershler, W., Satariano, W., Hazzard, W., Cohen, H. J., & Ferrucci, L. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.3.275 · Cited by 192
Vestal, R. E. (1997) · Cancer · Cited by 189
Kornblith, A. B., Kemeny, M., Peterson, B. L., Wheeler, J., Crawford, J., Bartlett, N., Fleming, G., Graziano, S., Muss, H., Cohen, H. J., et al. (2002) · Cancer · doi:10.1002/cncr.10792 · Cited by 180
Ishibashi, H., Suzuki, T., Suzuki, S., Niikawa, H., Lu, L., Miki, Y., Moriya, T., Hayashi, S.-I., Handa, M., Kondo, T., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3087 · Cited by 177
Crawford, J., Allen, J., Armitage, J., Blayney, D. W., Cataland, S. R., Heaney, M. L., Htoy, S., Hudock, S., Kloth, D. D., Kuter, D. J., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0075 · Cited by 177
Differences in initial treatment patterns and outcomes of lung cancer in the elderly
Smith, T. J., Penberthy, L., Desch, C. E., Whittemore, M., Newschaffer, C., Hillner, B. E., McClish, D., & Retchin, S. M. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)00496-3 · Cited by 172
Multimorbidity and Survival in Older Persons with Colorectal Cancer
Gross, C. P., Guo, Z., McAvay, G. J., Allore, H. G., Young, M., & Tinetti, M. E. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00973.x · Cited by 172
Wedding, U., Röhrig, B., Klippstein, A., Pientka, L., & Höffken, K. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0233-x · Cited by 171
Cummins, C. L., Wu, C., & Benet, L. Z. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.128388 · Cited by 166
Nose, N., Sugio, K., Oyama, T., Nozoe, T., Uramoto, H., Iwata, T., Onitsuka, T., & Yasumoto, K. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.3251 · Cited by 161
Gupta, S. K., & Lamont, E. B. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52461.x · Cited by 153
van Asperen, J., van Tellingen, O., Tijssen, F., Schinkel, A. H., & Beijnen, J. H. (1998) · British Journal of Cancer · doi:10.1038/sj.bjc.6690019 · Cited by 147
Wakelee, H. A., Wang, W. T., Schiller, J. H., Langer, C. J., Sandler, A. B., Belani, C. P., & Johnson, D. H. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31609-9 · Cited by 146
Distress in Older Patients With Cancer
Hurria, A., Li, D., Hansen, K., Patil, S. N., Gupta, R. M., Nelson, C. J., Lichtman, S. M., Tew, W. P., Hamlin, P. A., Zuckerman, E. L., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9463 · Cited by 143
Self-citationInfluence of Sex on Toxicity and Treatment Outcome in Small-Cell Lung Cancer
Singh, S., Parulekar, W. R., Murray, N., Feld, R. D., Evans, W. K., Tu, D., & Shepherd, F. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.171 · Cited by 141
Maas, H. A. A. M., Kruitwagen, R. F. P. M., Lemmens, V. E. P. P., Goey, S. H., & Janssen-Heijnen, M. L. G. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.12.026 · Cited by 140
Sokol, K. C., Knudsen, J. F., & Li, M. M. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00815.x · Cited by 138
Wiencke, J. K., Zheng, S., Lafuente, A., Lafuente, M. J., Grudzen, C. R., Wrensch, M., Miike, R., Ballesta, A. M., & Trías, M. (1999) · PubMed · Cited by 132
Song, Y. S., Lee, B. Y., & Hwang, E. S. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.11.008 · Cited by 129
Jemal, A., Ward, E., & Thun, M. J. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-416-2_1 · Cited by 123
Pharmacology of Cancer Chemotherapy in the Older Person
Baker, S. D., & Grochow, L. B. (1997) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30188-5 · Cited by 120
Hurria, A., Wong, F. L., Villaluna, D., Bhatia, R., Chung, C. T., Mortimer, J. E., Hurvitz, S. A., & Naeim, A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.6891 · Cited by 119
Self-citationKeating, N. L., Landrum, M. B., Klabunde, C. N., Fletcher, R. H., Rogers, S. O., Doucette, W. R., Tisnado, D. M., Clauser, S. B., & Kahn, K. L. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9434 · Cited by 118
Prospective Evaluation of the Pharmacokinetics and Toxicity Profile of Docetaxel in the Elderly
ten Tije, A. J., Verweij, J., Carducci, M. A., Graveland, W. J., Rogers, T., Pronk, T., Verbruggen, M. P., Dawkins, F. W., & Baker, S. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.082 · Cited by 114
Bressolle, F., Bologna, C., Kinowski, J., Sany, J., & Combe, B. G. (1998) · Annals of the Rheumatic Diseases · doi:10.1136/ard.57.2.110 · Cited by 110
Cancer of the Oldest Old: What we Have Learned from Autopsy Studies
Stanta, G., Campagner, L., Cavallieri, F., & Giarelli, L. (1997) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30182-4 · Cited by 106
Li, X., Hui, A., Sun, L., Hasegawa, K., Torzilli, G., Minagawa, M., Takayama, T., & Makuuchi, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1715 · Cited by 105
Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
for, A. G. E. O., Aparicio, T., Desrame, J., Lecomte, T., Mitry, E., Belloc, J., Etienney, I., Montembault, S., Vayre, L., Locher, C., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601310 · Cited by 101
Altered Pharmacokinetics in the Elderly
Yuen, G. J. (1990) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30615-3 · Cited by 98
Lichtman, S. M., Hollis, D. R., Miller, A. A., Rosner, G. L., Rhoades, C. A., Lester, E. P., Millard, F. E., Byrd, J. C., Cullinan, S. A., Rosen, D. M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.9289 · Cited by 97
Cassidy, J., Twelves, C. J., Cameron, D., Steward, W. P., O'Byrne, K. J., Jodrell, D. I., Banken, L., Goggin, T. K., Jones, D., Roos, B., et al. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051118 · Cited by 92
Wang, R., Gross, C. P., Halene, S., & Ma, X. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.02.005 · Cited by 90
Konety, B. R., Cowan, J. E., Carroll, P. R., & CaPSURE Investigators (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.01.044 · Cited by 86
Pharmacokinetics and tolerance of vinorelbine in elderly patients with metastatic breast cancer
Sorio, R., Robieux, I., Galligioni, E., Freschi, A., Colussi, A. M., Crivellari, D., Saracchini, S., & Monfardini, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00426-1 · Cited by 79
Heck, J., Albert, S. M., Franco, R., & Gorin, S. (2008) · Journal of The American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01848.x · Cited by 79
Age, comorbidity, treatment decision and prognosis in lung cancer
Blanco, J. A. G., Toste, I. S., Álvarez, R. F., Cuadrado, G. R., Gonzálvez, A. M., & Martin, I. J. G. (2008) · Age and Ageing · doi:10.1093/ageing/afn226 · Cited by 67
Holm, B., Mellemgaard, A., Skov, T., & Skov, B. G. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.8631 · Cited by 63
Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer
Zauderer, M. G., Patil, S. N., & Hurria, A. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0116-0 · Cited by 59
Self-citationCancer, aging and immunotherapy: lessons learned from animal models
Lustgarten, J. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0677-8 · Cited by 59
Population pharmacokinetics and pharmacodynamics of oral etoposide
Toffoli, G., Corona, G., Sorio, R., Robieux, I., Basso, B., Colussi, A. M., & Boiocchi, M. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01468.x · Cited by 58
Kaiser, J. C., Heidenreich, W., Monchaux, G., Morlier, J. P., & Collier, C. G. (2004) · Radiation and Environmental Biophysics · doi:10.1007/s00411-004-0251-x · Cited by 51
Association of MDM2 SNP309, Age of Onset, and Gender in Cutaneous Melanoma
Firoz, E. F., Warycha, M. A., Zakrzewski, J., Pollens, D., Wang, G., Shapiro, R. L., Berman, R. S., Pavlick, A. C., Manga, P., D, H. O. M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2678 · Cited by 44
Geriatric Assessment in Older Patients with Breast Cancer
Klepin, H. D., Mohile, S. G., & Hurria, A. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0016 · Cited by 42
Self-citationMicrosatellite mutations in buccal cells are associated with aging and head and neck carcinoma
Slebos, R. J. C., Li, M., Vadivelu, S., Burkey, B. B., Netterville, J. L., Sinard, R. J., Gilbert, J., Murphy, B. A., Chung, C. H., Shyr, Y., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604198 · Cited by 38
Pharmacological analysis of etoposide in elderly patients with lung cancer.
Ando, M., Minami, H., Ando, Y., Sakai, S., Shimono, Y., Sugiura, S., Saka, H., Shimokata, K., & Hasegawa, Y. (1999) · PubMed · Cited by 37
Personalizing Cancer Care: American Society of Clinical Oncology Presidential Address 2009
Schilsky, R. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.6827 · Cited by 35
Lung cancer survival in Spain and prognostic factors: A prospective, multiregional study
de Cos, J. S., Miravet, L., Abal, J., Núñez, A., Muñoz, F. J., García, L., Castañar, A. M., Montero, M., Hernández, J. H., & Alonso, M. Á. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.08.013 · Cited by 33
THE INFLUENCE OF OTHER DISEASES UPON THE OUTCOME OF COLORECTAL CANCER PATIENTS
Payne, J. E., & Meyer, H. W. (1995) · Australian and New Zealand Journal of Surgery · doi:10.1111/j.1445-2197.1995.tb01767.x · Cited by 32
Moscetti, L. I., Nelli, F., Padalino, D., Sperduti, I., Giannarelli, D., & Pollera, C. F. (2005) · Journal of Chemotherapy · doi:10.1179/joc.2005.17.6.685 · Cited by 18
Nguyen, P. L., Chen, M., Beard, C. J., Suh, W. W., Choueiri, T. K., Efstathiou, J. A., Hoffman, K. E., Loffredo, M. J., Kantoff, P. W., & D'Amico, A. V. (2009) · Cancer · doi:10.1002/cncr.24818 · Cited by 11
DECREASED CANCER PREVALENCE IN THE NURSING HOME
Kanapuru, B., Posani, K., Muller, D. C., & Ershler, W. B. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01864.x · Cited by 8
Cited by
Mohile, S. G., Dale, W., Somerfield, M. R., Schonberg, M. A., Boyd, C. M., Burhenn, P. S., Canin, B., Cohen, H. J., Holmes, H. M., Hopkins, J. O., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8687 · Cited by 1,479
Self-citationEAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
Witjes, J. A., Compérat, E., Cowan, N. C., De Santis, M., Gakis, G., Lebret, T., Ribal, M. J., Van der Heijden, A. G., & Sherif, A. (2014) · European Urology · doi:10.1016/j.eururo.2013.11.046 · Cited by 1,002
Sex- and gender-specific disparities in colorectal cancer risk
Kim, S.-E. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i17.5167 · Cited by 493
Sex differences in cancer mechanisms
Rubin, J. B., Lagas, J. S., Broestl, L., Sponagel, J., Rockwell, N., Rhee, G., Rosen, S. F., Chen, S., Klein, R. S., Imoukhuede, P., et al. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00291-x · Cited by 366
Versatile roles of extracellular vesicles in cancer
Kosaka, N., Yoshioka, Y., Fujita, Y., & Ochiya, T. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81130 · Cited by 348
Metadata
- Authors
- Pal, S. K., & Hurria, A.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-09-10
- Volume
- 28
- Issue
- 26
- Pages
- 4086-4093
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2119609623
- Cited by
- 265
- References
- 115
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.